News: Eckert & Ziegler AG (englisch)

Eckert & Ziegler to Nominate Independent Directors in Upcoming IBt Board Re-Shuffle


Berlin, 26.2.2010 - In light of the announcement of several resignations from the board of directors at International Brachytherapy (IBt), Eckert & Ziegler, a major shareholder of IBt, confirms its intention to nominate independent directors as replacements for the resigning incumbents. Eckert & Ziegler (ISIN DE0005659700) is not seeking for itself a majority in the board. The company hence strongly rejects speculations in the press about potential corporate governance issues at IBt.

'The independent directors and the management team will also in the future clearly maintain a majority in the board of directors of IBt', said Andreas Eckert, CEO of Eckert & Ziegler. 'Any suspicions that Eckert & Ziegler intends to run IBt as a puppet company are nonsense. Eckert & Ziegler has no desire or intention to micromanage IBt. We are interested in growth and profitability, not in status and favoritism. The move of Eckert & Ziegler and SMI to enlarge its board influence in the upcoming shareholder meeting of 3 March is defensive and solely driven by the desire to implement a sustainable winning culture.

Eckert added: 'It is indicative that the resignations, as well as the sudden public worries about corporate governance issues, have come exclusively from persons that were responsible for the year-long agony of IBt prior to the arrival of Eckert & Ziegler. By contrast, the new independent director and the new management team that came on board later, have not voiced any concern about the proposed changes. They understand that the existing relations of Eckert & Ziegler and SMI are not a threat, but an opportunity for the prospects of IBt.'

Your contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations, Robert-Rössle-Str.
10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, Fax -112, E-Mail: karolin.riehle@ezag.de,
www.ezag.de

Eckert & Ziegler Strahlen- und Medizintechnik AG

Robert-Rössle-Str.10

13125 Berlin

Deutschland

Phone: 49 30 941084-138

Fax: 49 30 941084-112

E-Mail: karolin.riehle@ezag.de

Internet: www.ezag.de

ISIN: DE0005659700, DE000A0L1L69 WKN: 565970, A0L1L6

Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, München, Düsseldorf, Hamburg

Source: Eckert & Ziegler AG